{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:03:10Z","timestamp":1794441790673,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":43,"publisher":"Springer New York","isbn-type":[{"value":"9781461461104","type":"print"},{"value":"9781461461111","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-4614-6111-1_14","type":"book-chapter","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T08:30:37Z","timestamp":1362558637000},"page":"267-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunization Strategies Against Pulmonary Tuberculosis: Considerations of T Cell Geography"],"prefix":"10.1007","author":[{"given":"Carly N.","family":"Horvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"14_CR1","unstructured":"World Health Organization (2009) Global tuberculosis control. World Health Organization, Geneva"},{"issue":"4","key":"14_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.coi.2009.06.004","volume":"21","author":"AM Cooper","year":"2009","unstructured":"Cooper AM (2009) T cells in mycobacterial infection and disease. Curr Opin Immunol 21(4):378\u2013384","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"14_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27(1):393\u2013422","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"14_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.it.2010.05.002","volume":"31","author":"M Jeyanathan","year":"2010","unstructured":"Jeyanathan M, Heriazon A, Xing Z (2010) Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Trends Immunol 31(7):247\u2013252","journal-title":"Trends Immunol"},{"issue":"11","key":"14_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1586\/erv.09.110","volume":"8","author":"Z Xing","year":"2009","unstructured":"Xing Z (2009) Importance of T-cell location rekindled: Implication for tuberculosis vaccination strategies. Expert Rev Vaccines 8(11):1465\u20131468","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"14_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1586\/14760584.7.5.635","volume":"7","author":"LH Ly","year":"2008","unstructured":"Ly LH, McMurray DN (2008) Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines 7(5):635\u2013650","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"14_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1586\/14760584.6.4.539","volume":"6","author":"Z Xing","year":"2007","unstructured":"Xing Z, Charters TJ (2007) Heterologous boost vaccines for bacillus Calmette-Guerin prime immunization against tuberculosis. Expert Rev Vaccines 6(4):539\u2013546","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"14_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.coi.2010.04.006","volume":"22","author":"SK Parida","year":"2010","unstructured":"Parida SK, Kaufmann SH (2010) Novel tuberculosis vaccines on the horizon. Curr Opin Immunol 22(3):374\u2013384","journal-title":"Curr Opin Immunol"},{"key":"14_CR9","doi-asserted-by":"crossref","unstructured":"Shaler C, Horvath C, Lai R, Xing Z (2012) Understanding delayed T cell priming, lung recruitment and airway luminal T cell responses in host defense against pulmonary tuberculosis. Clin Dev Immunol 2012:628293","DOI":"10.1155\/2012\/628293"},{"issue":"4","key":"14_CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/mi.2012.19","volume":"5","author":"C Horvath","year":"2012","unstructured":"Horvath C, Shaler CR, Jeyanathan M, Zganiacz A, Xing Z (2012) Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral-BCG vaccinated hosts: a critical role of airway luminal T cells. Mucosal Immunol 5(4):420\u2013431","journal-title":"Mucosal Immunol"},{"issue":"4","key":"14_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1365-2567.2009.03141.x","volume":"128","author":"D Begum","year":"2009","unstructured":"Begum D et al (2009) Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette\u2013Gu\u00e9rin. Immunology 128(4):556\u2013563","journal-title":"Immunology"},{"issue":"2","key":"14_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","volume":"69","author":"H McShane","year":"2001","unstructured":"McShane H et al (2001) Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun 69(2):681\u2013686","journal-title":"Infect Immun"},{"issue":"1","key":"14_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2217\/17460913.1.1.63","volume":"1","author":"K Huygen","year":"2006","unstructured":"Huygen K (2006) DNA vaccines against mycobacterial diseases. Future Microbiol 1(1):63\u201373","journal-title":"Future Microbiol"},{"issue":"12","key":"14_CR14","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1086\/425931","volume":"190","author":"TM Doherty","year":"2004","unstructured":"Doherty TM et al (2004) Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 190(12):2146\u20132153","journal-title":"J Infect Dis"},{"issue":"7","key":"14_CR15","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.vaccine.2006.09.089","volume":"25","author":"X Zhang","year":"2007","unstructured":"Zhang X et al (2007) Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine 25(7):1342\u20131352","journal-title":"Vaccine"},{"issue":"10","key":"14_CR16","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","volume":"173","author":"J Wang","year":"2004","unstructured":"Wang J et al (2004) Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 173(10):6357\u20136365","journal-title":"J Immunol"},{"issue":"3","key":"14_CR17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","volume":"171","author":"NP Goonetilleke","year":"2003","unstructured":"Goonetilleke NP et al (2003) Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 171(3):1602\u20131609","journal-title":"J Immunol"},{"issue":"8","key":"14_CR18","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.4049\/jimmunol.181.8.5618","volume":"181","author":"M Jeyanathan","year":"2008","unstructured":"Jeyanathan M et al (2008) Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung. J Immunol 181(8):5618\u20135626","journal-title":"J Immunol"},{"issue":"8","key":"14_CR19","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1128\/IAI.00004-07","volume":"75","author":"K Radosevic","year":"2007","unstructured":"Radosevic K et al (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75(8):4105\u20134115","journal-title":"Infect Immun"},{"issue":"1","key":"14_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","volume":"72","author":"L Chen","year":"2004","unstructured":"Chen L et al (2004) Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun 72(1):238\u2013246","journal-title":"Infect Immun"},{"issue":"5","key":"14_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jinf.2005.12.017","volume":"53","author":"PK Giri","year":"2006","unstructured":"Giri PK, Verma I, Khuller GK (2006) Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice. J Infect 53(5):350\u2013356","journal-title":"J Infect"},{"issue":"12","key":"14_CR22","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1073\/pnas.0800043105","volume":"105","author":"L Garcia-Contreras","year":"2008","unstructured":"Garcia-Contreras L et al (2008) Immunization by a bacterial aerosol. Proc Nat Acad Sci U S A 105(12):4656\u20134660","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"1","key":"14_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2249.1992.tb06419.x","volume":"87","author":"RD Hubbard","year":"1992","unstructured":"Hubbard RD, Flory CM, Collins FM (1992) Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 87(1):94\u201398","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"14_CR24","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.166.10.6227","volume":"166","author":"RN Coler","year":"2001","unstructured":"Coler RN et al (2001) Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J immunol 166(10):6227\u20136235","journal-title":"J immunol"},{"issue":"1","key":"14_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.femsim.2005.02.009","volume":"45","author":"PK Giri","year":"2005","unstructured":"Giri PK et al (2005) Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis. FEMS Immunol Med Microbiol 45(1):87\u201393","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3\u20134","key":"14_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","volume":"86","author":"Z Xing","year":"2006","unstructured":"Xing Z, Lichty BD (2006) Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization. Tuberculosis 86(3\u20134):211\u2013217","journal-title":"Tuberculosis"},{"issue":"8","key":"14_CR27","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/mt.2009.130","volume":"17","author":"MO Lasaro","year":"2009","unstructured":"Lasaro MO, Ertl HC (2009) New insights on adenovirus as vaccine vectors. Mol Ther 17(8):1333\u20131339","journal-title":"Mol Ther"},{"issue":"12","key":"14_CR28","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","volume":"174","author":"M Santosuosso","year":"2005","unstructured":"Santosuosso M et al (2005) Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol 174(12):7986\u20137994","journal-title":"J Immunol"},{"issue":"8","key":"14_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1164\/rccm.200910-1583OC","volume":"181","author":"M Jeyanathan","year":"2010","unstructured":"Jeyanathan M et al (2010) Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment. Am J Respir Crit Care Med 181(8):862\u2013872","journal-title":"Am J Respir Crit Care Med"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jgm.1487","volume":"12","author":"J Mu","year":"2010","unstructured":"Mu J, Jeyanathan M, Shaler CR, Horvath C, Damjanovic D, Zganiacz A, Kugathasan K, McCormick S, Xing Z (2010) Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell-independent protective immunity. J Gene Med 12:693\u2013704","journal-title":"J Gene Med"},{"issue":"8","key":"14_CR31","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1128\/IAI.00004-07","volume":"75","author":"K Radosevic","year":"2007","unstructured":"Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, van der Poll T, Havenga M, Goudsmit J (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75(8):4105\u20134115","journal-title":"Infect Immun"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/mt.2008.59","volume":"16","author":"EK Roediger","year":"2008","unstructured":"Roediger EK, Kugathasan K, Zhang X, Lichty BD, Xing Z (2008) Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus vectored vaccine for pulmonary tuberculosis. Mol Ther 16:1161\u20131169","journal-title":"Mol Ther"},{"issue":"9","key":"14_CR33","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","volume":"177","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, Andersen P (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177(9):6353\u20136360","journal-title":"J Immunol"},{"issue":"1","key":"14_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1128\/IAI.01290-06","volume":"75","author":"CS Andersen","year":"2007","unstructured":"Andersen CS, Dietrich J, Agger EM, Lycke NY, L\u00f6vgren K, Andersen P (2007) The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Infect Immun 75(1):408\u2013416","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"14_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tube.2004.09.013","volume":"85","author":"M Haile","year":"2005","unstructured":"Haile M et al (2005) Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL\/6 mice. Tuberculosis 85(1\u20132):107\u2013114","journal-title":"Tuberculosis"},{"issue":"21","key":"14_CR36","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1016\/j.vaccine.2005.08.048","volume":"24","author":"SC Gilbert","year":"2006","unstructured":"Gilbert SC et al (2006) Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 24(21):4554\u20134561","journal-title":"Vaccine"},{"issue":"8","key":"14_CR37","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1128\/IAI.00517-06","volume":"74","author":"M Santosuosso","year":"2006","unstructured":"Santosuosso M et al (2006) Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect Immun 74(8):4634\u20134643","journal-title":"Infect Immun"},{"issue":"7","key":"14_CR38","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","volume":"181","author":"EK Forbes","year":"2008","unstructured":"Forbes EK et al (2008) Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 181(7):4955\u20134964","journal-title":"J Immunol"},{"issue":"12","key":"14_CR39","doi-asserted-by":"publisher","first-page":"e8235","DOI":"10.1371\/journal.pone.0008235","volume":"4","author":"EO Ronan","year":"2009","unstructured":"Ronan EO, Lee LN, Beverley PC, Tchilian EZ (2009) Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection. PLoS ONE 4(12):e8235","journal-title":"PLoS ONE"},{"issue":"6","key":"14_CR40","doi-asserted-by":"publisher","first-page":"e5856","DOI":"10.1371\/journal.pone.0005856","volume":"4","author":"Z Xing","year":"2009","unstructured":"Xing Z, McFarland CT, Sallenave JM, Izzo A, Wang J, McMurray DN (2009) Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed uinea pigs against pulmonary tuberculosis. PLoS ONE 4(6):e5856","journal-title":"PLoS ONE"},{"issue":"11","key":"14_CR41","doi-asserted-by":"publisher","first-page":"e27477","DOI":"10.1371\/journal.pone.0027477","volume":"6","author":"EZ Tchilian","year":"2011","unstructured":"Tchilian EZ, Ronan EO, de Lara C, Lee LN, Franken KL, Vordermeier MH, Ottenhoff TH, Beverley PC (2011) Simultaneous immunization against tuberculosis. PLoS ONE 6(11):e27477","journal-title":"PLoS ONE"},{"issue":"4","key":"14_CR42","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.178.4.2387","volume":"178","author":"M Santosuosso","year":"2007","unstructured":"Santosuosso M et al (2007) Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J Immunol 178(4):2387\u20132395","journal-title":"J Immunol"},{"key":"14_CR43","unstructured":"Wooley J (2011) Tuberculosis vaccine candidates\u20142011. Stop TB Partnership. Available via Tuberculosis Vaccine Initiative. http:\/\/www.tbvi.eu\/fileadmin\/user_upload\/Documenten\/News\/TB_Vaccine_Pipeline_2011_FINAL03042012.pdf. Accessed August 2012"}],"container-title":["Advances in Experimental Medicine and Biology","The New Paradigm of Immunity to Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-6111-1_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T15:18:15Z","timestamp":1675091895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4614-6111-1_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781461461104","9781461461111"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-6111-1_14","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4614-6111-1","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"7 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}